We quantified CSF 14-3-3γ in 72 sCJD and 73 Non-CJD patients, by a new ELISA assay.
WB and ELISA 14-3-3γ results matched in 81% of all cases.
WB inconclusive cases were further discriminated by ELISA 14-3-3γ assay.
ELISA 14-3-3γ is the best single predictive marker for sCJD early diagnosis.
PRNP genotype did not influence ELISA 14-3-3γ protein levels.